ketanserin has been researched along with Blood Loss, Surgical in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Blood Loss, Surgical: Loss of blood during a surgical procedure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van EE, R | 1 |
| van Oene, JC | 1 |
1 trial available for ketanserin and Blood Loss, Surgical
| Article | Year |
|---|---|
Effect of ketanserin on intraoperative blood loss during total hip arthroplasty in elderly patients under general anaesthesia.
Topics: Age Factors; Aged; Anesthesia, General; Arteries; Blood Loss, Surgical; Blood Pressure; Female; Hip | 1991 |